Provided by Tiger Trade Technology Pte. Ltd.

INNOVENT BIO

79.400
-3.150-3.82%
Volume:8.01M
Turnover:647.28M
Market Cap:137.76B
PE:-1.32K
High:83.500
Open:82.550
Low:79.200
Close:82.550
52wk High:109.100
52wk Low:36.600
Shares:1.74B
HK Float Shares:1.74B
Volume Ratio:0.76
T/O Rate:0.46%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.060
ROE:8.43%
ROA:2.65%
PB:8.44
PE(LYR):-1,323.33
PS:10.65

Loading ...

INNOVENT BIO Shares Surge Over 4% on Strategic Collaboration with Eli Lilly Potentially Worth $8.85 Billion

Stock News
·
Feb 09

INNOVENT BIO and Eli Lilly Form Global Strategic Alliance to Advance Oncology and Immunology Drug Development

Stock News
·
Feb 08

Innovent (1801) Announces Seventh Collaboration with Lilly to Develop Global Oncology and Immunology Medicines

Bulletin Express
·
Feb 08

Innovent Announces Strategic Collaboration With Lilly To Develop New Medicines Globally In Oncology And Immunology

Reuters
·
Feb 08

Innovent Biologics and Eli Lilly Announce Global Oncology and Immunology Collaboration

Reuters
·
Feb 08

Innovent Announces Strategic Collaboration With Lilly to Develop New Medicines Globally in Oncology and Immunology

THOMSON REUTERS
·
Feb 08

Innovent Biologics: Is Eligible to Receive Development, Regulatory & Commercial Milestone Payments up to Est $8.5 Bln Contingen Certain Future Events

THOMSON REUTERS
·
Feb 08

Innovent Biologics - Innovent Will Receive a $350 Mln Upfront Payment

THOMSON REUTERS
·
Feb 08

JPMorgan Boosts Stake in Innovent Bio by Approximately 1.23 Million Shares at HK$78.70 Each

Stock News
·
Feb 06

Goldman Sachs Raises INNOVENT BIO's Profit Forecasts, Maintains Buy Rating with HK$102.85 Target

Stock News
·
Feb 06

Innovent Biologics (01801) Announces Monthly Return on Movements in Securities for January 2026

Bulletin Express
·
Feb 05

Innovent Bio Shares Slip Nearly 4% Following One-Time Channel Inventory Provision; Institutions Affirm Q4 Performance Meets Expectations

Stock News
·
Feb 05

Hong Kong Stock Announcement Highlights | Yum China's 2025 Operating Profit Rises 11% to $1.3 Billion

Stock News
·
Feb 04

INNOVENT BIO (01801) Reports Total Product Revenue of Approximately RMB 11.9 Billion in 2025, Maintaining Robust Growth of About 45% Year-on-Year

Stock News
·
Feb 04

Innovent Biologics (1801) Reports Strong 2025 Product Revenue Growth

Bulletin Express
·
Feb 04

Innovent Biologics - for the Full Year of 2025, the Total Product Revenue RMB11.9 Billion

THOMSON REUTERS
·
Feb 04

Innovent Biologics Reports 45% Year-Over-Year Growth in 2025 Product Revenue

Reuters
·
Feb 04

JPMorgan Increases Stake in Innovent Bio (01801) by Approximately 199,000 Shares at HK$83.83 Per Share

Stock News
·
Feb 03

Novo Nordisk's China President Zhou to step down in March

Reuters
·
Jan 30

Valuation Ranges of Biopharma: Insights from Innovent Biologics, Hengrui Pharmaceuticals, and BeiGene

Deep News
·
Jan 30